Image-guided conformation arc therapy for prostate cancer: Early side effects

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 4 SUPPL., 2006, Pages

  Soete, Guy ^a   Verellen, Dirk ^a   Michielsen, Dirk ^a   Rappe, Bernard ^b   Keuppen, Frans ^a   Storme, Guy ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b Algemeen Stedelijk Ziekenhuis   (Belgium)

Author keywords

Conformal radiotherapy; Image guided radiotherapy; Prostate cancer

Indexed keywords

HORMONES; ONCOLOGY; OPTICAL COLLIMATORS; TOXICITY; TUMORS;

CONFORMAL RADIOTHERAPY; IMAGE GUIDED RADIOTHERAPY; PATIENT POSITIONING; PROSTATE CANCER;

RADIOTHERAPY;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; DIGESTIVE SYSTEM INJURY; FOLLOW UP; HORMONAL THERAPY; HUMAN; IMAGE GUIDED CONFORMATION ARC THERAPY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; SCORING SYSTEM; UROGENITAL TRACT DISEASE;

EID: 33750355374     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.05.077     Document Type: Article

References (24)

1. Hanks G.E., Schultheiss T.E., Hanlon A.L., et al. Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. Int J Radiat Oncol Biol Phys 37 (1997) 543-550
2. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41 (1998) 491-500
3. Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol 18 (2000) 3904-3911
4. Kupelian P.A., Mohan D.S., Lyons J., et al. Higher than standard radiation doses (≥72 Gy) with or without androgen deprivation in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 46 (2000) 567-574
5. Schultheiss T.E., Lee W.R., Hunt M.A., et al. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys 37 (1997) 3-11
6. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
7. Storey M.R., Pollack A., Zagars G., et al. Complications from radiotherapy dose-escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys 48 (2000) 635-642
8. Lyons J.A., Kupelian P.A., Mohan D.S., et al. Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate. Urology 55 (2000) 85-90
9. Hanks G.E., Hanlon A.L., Pinover W.H., et al. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys 46 (2000) 823-832
10. Kestin L., Goldstein N., Vicini F., et al. Treatment of prostate cancer with radiotherapy: Should the entire seminal vesicles be included in the clinical target volume?. Int J Radiat Oncol Biol Phys 54 (2002) 686-697
11. Pisansky T.M., Zincke H., Suman V.J., et al. Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys 34 (1996) 33-39
12. Pisansky T.M., Blute M.L., Suman V.J., et al. Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens. Int J Radiat Oncol Biol Phys 36 (1996) 585-591
13. van Herk M., Remeijer P., Rasch C., et al. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 1121-1135
14. McKenzie A., van Herk M., and Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol 62 (2002) 299-307
15. Soete G., Verellen D., Michielsen D., et al. Clinical use of stereoscopic X-ray positioning of patients treated with conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54 (2002) 948-952
16. Verellen D., Soete G., Linthout N., et al. Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging. Radiother Oncol 67 (2003) 129-141
17. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
18. Pavy J.J., Denekamp J., Letschert J., et al. Late effects toxicity scoring: The SOMA scale. Int J Radiat Oncol Biol Phys 31 (1995) 1043-1049
19. ASTRO Consensus Panel. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37 (1997) 1035-1041
20. Kupelian P.A., Potters L., Khuntia D., et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or = 72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 58 (2004) 25-33
21. Vijayakumar S., Awan A., Karrison T., et al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: Comparison of different techniques. Int J Radiat Oncol Biol Phys 25 (1993) 359-371
22. Hanks G.E., Schultheiss T.E., Hunt M.A., et al. Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys 31 (1995) 25-29
23. Vicini F.A., Kestin L.L., and Martinez A.A. The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 45 (1999) 553-561
24. Diaz A., Roach III M., Marquez C., et al. Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 30 (1994) 323-329